Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 18/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.69 |
| ▸ | ACHE | P22303 | 1/20 | 0.69 |
| ▸ | RAD52 | P43351 | 1/20 | 0.69 |
| ▸ | HRH1 | P35367 | 1/20 | 0.67 |
| ▸ | PDE1A | P54750 | 1/20 | 0.66 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.66 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 2/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2819407 | 1.00 | HRH3 (0.75) | HRH3KCNH2ACHERAD52HRH1 | |
| SCHEMBL73562 | 0.98 | HRH3 (0.72) | HRH3KCNH2ACHERAD52HRH1 | |
| SCHEMBL12834986 | 0.95 | HRH3 (0.73) | HRH3KCNH2PDE1APDE1BPDE1C | |
| SCHEMBL16358313 | 0.93 | HRH3 (0.71) | HRH3KCNH2PDE1APDE1BPDE1C | |
| SCHEMBL4708977 | 0.91 | PSMB1 (0.70) | HRH3PDE1APDE1BPDE1C | |
| SCHEMBL1778223 | 0.91 | PSMB1 (0.70) | HRH3PDE1APDE1BPDE1C | |
| SCHEMBL3581930 | 0.91 | HRH3 (0.89) | HRH3KCNH2ACHERAD52HRH1 | |
| SCHEMBL4517043 | 0.89 | PSMB1 (0.67) | HRH3PDE1APDE1BPDE1C | |
| SCHEMBL3578646 | 0.87 | HRH3 (0.90) | HRH3KCNH2ACHERAD52HRH1 | |
| SCHEMBL4094339 | 0.86 | HRH3 (1.00) | HRH3KCNH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2704578-A2 | IMPROVED HONEYBEE REPELLENTS AND USES THEREOF | Inscent, Inc. (US) | 2014-03-12 | — | — | EP | claimed |
| WO-2012151556-A2 | IMPROVED HONEYBEE REPELLENTS AND USES THEREOF | INSCENT, INC. (US) | 2012-11-08 | — | — | WO | claimed |
| US-11963527-B2 | Compounds, compositions, and methods for altering insect and organism behavior | BASF CORPORATION (US) | 2024-04-23 | — | — | US | disclosed |
| WO-2020206491-A1 | BEE REPELLENT | EcoKimiko IPM Pty Ltd (AU) | 2020-10-15 | — | — | WO | disclosed |
| US-20190104732-A1 | Compounds, Compositions, and Methods for Altering Insect and Organism Behavior | BASF CORPORATION | 2019-04-11 | — | — | US | disclosed |
| US-10098352-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2018-10-16 | — | — | US | disclosed |
| US-20160330960-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160330960-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160330960-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2016-11-17 | — | — | US | disclosed |
| US-9439434-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2016-09-13 | — | — | US | disclosed |
| US-9439434-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2016-09-13 | — | — | US | disclosed |
| WO-2004089373-A1 | 4- (4-(HETEROCYCLYLALKOXY}PHENYL)-1-(HETEROCYCLYL-CARBONYL)PIPERIDINE DERIVATIVES AND RELATED COMPOUNDS AS HISTAMINE H3 ANTAGONISTS FOR THE TREATMENT OF NEUROLOGICAL DISEASES SUCH AS ALZHEIMER’S | GLAXO GROUP LIMITED (GB) | 2004-10-21 | — | — | WO | disclosed |
| US-20040167336-A1 | Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine | APODACA RICHARD (US) | 2004-08-26 | — | — | US | disclosed |
| WO-2004035556-A1 | SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2004-04-29 | — | — | WO | disclosed |
| EP-1326863-A2 | OCTAHYDRO-INDOLIZINES AND QUINOLIZINES AND HEXAHYDRO-PYRROLIZINES | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-07-16 | — | — | EP | disclosed |
| EP-1313721-A2 | NON-IMIDAZOLE ARYLOXYALKYLAMINES AS H3 RECEPTOR LIGANDS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-05-28 | — | — | EP | disclosed |
| US-20030013733-A1 | Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine | ORTHO MCNEIL PHARMACEUTICAL, INC. | 2003-01-16 | — | — | US | disclosed |
| US-20020065278-A1 | Non-imidazole aryloxyalkylamines | ORTHO MCNEIL PHARMACEUTICAL, INC. | 2002-05-30 | — | — | US | disclosed |
| WO-2002024695-A2 | OCTAHYDRO-INDOLIZINES AND QUINOLIZINES AND HEXAHYDRO-PYRROLIZINES | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002012214-A2 | NON-IMIDAZOLE ARYLOXYALKYLAMINES AS H3 RECEPTOR LIGANDS | ORTHO MCNEIL PHARMACEUTICAL INC. (US) | 2002-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160330960-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | HRH3 263/4885KCNH2 1330/4885ACHE 1/4885 |
| US-10098352-B2 | Honeybee repellents and uses thereof | ACHE, AHNAK, L3MBTL3 | HRH3 263/4885KCNH2 1330/4885ACHE 1/4885 |
| US-20020065278-A1 | Non-imidazole aryloxyalkylamines | HNMT, HRH2, HRH3 | HRH3 3/4885KCNH2 470/4885ACHE 506/4885 |
| US-11963527-B2 | Compounds, compositions, and methods for altering insect and organism behavior | ACHE, DDT, MGLL | HRH3 2662/4885KCNH2 4464/4885ACHE 1/4885 |
| US-20030013733-A1 | Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine | HRH4, HNMT, HRH1 | HRH3 7/4885KCNH2 488/4885ACHE 119/4885 |
| US-20190104732-A1 | Compounds, Compositions, and Methods for Altering Insect and Organism Behavior | ACHE, DDT, MGLL | HRH3 2662/4885KCNH2 4464/4885ACHE 1/4885 |
| US-20040167336-A1 | Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine | HRH4, HNMT, HRH1 | HRH3 7/4885KCNH2 488/4885ACHE 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.